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A total of 6% of 6,983 households in the United
Kingdom had leftover antimicrobial drugs, and 4% had
standby antimicrobial drugs. Respondents with leftover
drugs were more educated, more knowledgeable about
antimicrobial drugs, younger, and female. Of respondents
with leftover drugs, 44% kept them in case of future need,
and 18% had taken these drugs without medical advice.
A
ntimicrobial drug resistance is increasing worldwide
and is related to use of these drugs (1,2). Use of left-
over drugs may increase antimicrobial drug resistance in
the community by exerting selective pressure in the com-
mensal flora (3,4). Retention and use of leftover antimicro-
bial drugs are widespread in countries that sell
antimicrobial drugs without a prescription (i.e., over-the-
counter) (5,6). In countries in which over-the-counter
antimicrobial drug sales are restricted, studies on use of
leftover drugs have been few and mostly questionnaire-
based, relying on respondent recall (7,8). Alarge survey of
British household drug practices showed that 2% of medi-
cines were leftover or standby drugs (9), but no informa-
tion was obtained about the households containing them.
To inform antimicrobial drug education campaigns (10,11)
and research examining the relationship between antimi-
crobial drug prescribing and resistance (12), we conducted
a household survey to identify antimicrobial drugs present
and the characteristics of respondents who kept them.
Methods
The survey formed part of the Office for National
Statistics’ Omnibus Survey in the United Kingdom in
February, March, June, and July 2003. A representative
sample of households was selected by using previously
published methods (9). Households were invited by letter
to participate in a study about their views and experiences
on a variety of subjects. For households with >1 adult
member, 1 person >16 years of age was selected by a ran-
dom number tables. At the household visit, respondents
were informed that the survey was sponsored by the
department of health and was about drugs for treating
infections. Respondents were asked to show the interview-
er all drugs in the household that had been prescribed for
infections, even if the person for whom they were pre-
scribed was not present (temporarily or permanently), and
asked whether the drugs were currently being used for an
infection for which they were prescribed, had been pre-
scribed for a previous infection (leftover drugs), or were
being kept for use in the future (standby drugs). The
amount of unused drug was noted and prescription details
were recorded and coded by their listing in the British
National Formulary. Antimicrobial drugs included all anti-
fungal and antibacterial drugs.
Respondents were asked a series of questions about
their use of antimicrobial drugs and whether they agreed or
disagreed with a series of statements from education cam-
paigns (10,11) about the usefulness of these drugs for
coughs and colds, viruses, bacteria, and normal flora; the
importance of completing courses of drug therapy, and
antimicrobial drug resistance. Ethical approval was not
required for this ongoing national survey, but respondents
were able to refuse participation in any part of the survey
at any time and were told that all information was anony-
mous and strictly confidential.
To enable comparison with nationally prescribed
antimicrobial drugs, the number of community-prescribed
drugs in England was obtained from prescribing analysis
and cost data (PACT) (13). Sampling weights based on the
2001 census data for Great Britain were applied to house-
hold and respondent data to allow for any oversampling or
undersampling by region, Carstair’s deprivation quintile,
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(ignoring sampling weights) was used to investigate inde-
pendent associations between respondent characteristics
and the presence of leftover antimicrobial drugs prescribed
for the respondent.
Results
Of 10,981 selected households, 25% refused to partici-
pate and 10% could not be contacted. Respondents in
7,120 (65%) households completed the questionnaire and
6,983 (64%) agreed to the drug survey. A total of 19% of
the 6,983 households had an antimicrobial drug leftover
(6%), kept for standby use (4%), or currently in use (11%)
(Table 1). Six percent of leftover drugs had been pre-
scribed for <3 days, 16% for 4–5 days, 61% for >6 days,
and 17% were to be taken as required. No specific class of
oral antimicrobial drugs was kept more often as leftover
drugs relative to PACT prescription rates (Figure 1).
Four percent of respondents had leftover antimicrobial
drugs that had been prescribed. The most educated respon-
dents were twice as likely as those least educated to have
leftover antimicrobial drugs (5.4% with a university
degree vs. 2.4% with no formal degree) (Table 2).
Respondents most knowledgeable about antimicrobial
drugs (6.1% if all 11 questions were answered correctly)
were twice as likely as those least knowledgeable (3.1% if
>5 were answered incorrectly) to keep them (Table 2,
Figure 2). Level of education and knowledge of antimicro-
bial drugs were independently associated with being more
likely to have leftover drugs (Table 2). Younger respon-
dents and women were more likely to have leftover drugs
(Table 2, Figure 2). Thirty-eight percent of respondents’
leftover drugs had been dispensed >1 year earlier, and 48%
of these drugs had more than half of the original amount
remaining (Table 1). Of those who had kept a leftover
antimicrobial drug prescribed in the past year, 44% did so
for future need (Table 1). Of those with a leftover drug,
18% had taken antimicrobial drugs without advice com-
pared with 4% of respondents who did not have a leftover
drug (p<0.0005).
When directly questioned, 38% of respondents (95%
confidence interval 36.4–38.8%) recalled that they had
been prescribed a drug in the past year. Younger age in
women (50% if 16–24 years of age, 43% if 25–44 years of
age, and 44% if 45–54 years of age) and lower level of
education (33% with a degree and 40% with no formal
qualifications on leaving school at the minimum age [16
years]) were independently associated with being pre-
scribed an antimicrobial drug.
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Figure 1. Oral leftover antimicrobial drugs compared with prescrip-
tions issued (p = 0.16), United Kingdom, 2003. PACT, prescribing
analysis and cost data.Discussion
This large survey of household antimicrobial drugs,
which was conducted in a country with restricted over-the-
counter sales, showed an association between keeping left-
over antimicrobial drugs and higher education and
knowledge about these drugs, younger age, and being
female. The strength of this study is that we asked a large
representative sample to show us their antimicrobial drugs
rather than relying on respondent memory. However, we
may not have been shown all antimicrobial drugs, and
some of the leftover drugs may have been misclassified as
standby drugs. The characteristics of respondents in house-
holds with standby drugs were similar to those of respon-
dents with leftover drugs. The number of antimicrobial
drugs found was twice that found by a recent survey in
Sweden that relied on respondent recall; in that study, the
respondents also reported a lower number of antimicrobial
drug prescriptions (8).
Persons may keep leftover antimicrobial drugs because
too much was prescribed for their initial infection. Most
community-acquired infections are respiratory or urinary,
for which many prescribed courses of antimicrobial drugs
are longer than necessary (14). If the standard duration of
treatment could be shortened and package size reduced to
contain enough drug for 3 to 5 days, the temptation to keep
antimicrobial drugs might be diminished. Our finding sup-
ports this suggestion because prescriptions for >6 days
constituted 61% of leftover drugs, whereas prescriptions
for <3 days constituted 6% of leftover drugs. Evidence
shows that repeated treatment with antimicrobial drugs
exerts greater selective pressure on normal bacterial flora
than a single course of treatment (14,15). Consequently,
persons who use leftover antimicrobial drugs repeatedly
are at greater risk for colonization and infection with drug-
resistant organisms (1,3,4,15).
Our results show that any public education campaign to
reduce retention and use of leftover antimicrobial drugs
must be directed at well-educated groups rather than the
less educated, who are prescribed more antimicrobial
drugs. One explanation may be that well-educated people
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antimicrobial drug use, and this may be particularly rele-
vant when their infection is less severe or becomes asymp-
tomatic. Furthermore, they do not discard these drugs
because 44% of those with leftover antimicrobial drugs
admitted keeping them in case of future need.
Antimicrobial drug education campaigns should reinforce
the message that leftover drugs should be returned to the
pharmacist or that these drugs should only be taken after
the advice of a health professional.
Our finding of high levels of leftover antimicrobial
drugs suggests that prescription does not equate to use.
This will be an important source of bias in epidemiologic
studies examining risk factors for antimicrobial drug
resistance (12) that include dose and duration of antimicro-
bial drug treatment in their analysis of exposure (1,4).
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Figure 2. Percentage of respondents with a leftover antimicrobial
drug (all antimicrobial drugs, i.e., antibacterial plus antifungal
drugs) by A) age (y) of respondent (p = 0.01, by test for trend) and
B) no. of attitude questions answered incorrectly (p = 0.002, by
test for trend). Error bars show 95% confidence intervals.